Inventor · disambiguated record
Stefan Dengl
Also filed as: DENGL STEFAN · DENGL STEFAN C
27 granted patents·31 pending applications·68 citations·filing 2014–2025
94Inventor score
Top patents by PatentIndex Score
58 records- 0197US10323089B2Anti-transferrin receptor antibodies with tailored affinityHOFFMANN LA ROCHE·Filed 2017·Granted Jun 18, 2019·25 cites·9 claims
- 0295US11584793B2Anti-transferrin receptor antibodies with tailored affinityHOFFMANN LA ROCHE·Filed 2019·Granted Feb 21, 2023·8 cites·20 claims
- 0394US12252533B2Anti-transferrin receptor antibodies with tailored affinityHOFFMANN LA ROCHE·Filed 2022·Granted Mar 18, 2025·1 cites·11 claims
- 0491US10822402B2Humanized anti-tau(pS422) antibodies and methods of useHOFFMANN LA ROCHE·Filed 2017·Granted Nov 3, 2020·4 cites·12 claims
- 0587US10434184B2Anti-TPBG antibodies and methods of useHOFFMANN LA ROCHE·Filed 2018·Granted Oct 8, 2019·3 cites·22 claims
- 0685US9862763B2Humanized anti-tau(pS422) antibodies and methods of useHOFFMANN LA ROCHE·Filed 2016·Granted Jan 9, 2018·4 cites·13 claims
- 0784US12297263B2Humanized anti-Tau(PS422) antibodies and methods of useHOFFMANN LA ROCHE·Filed 2022·Granted May 13, 2025·0 cites·6 claims
- 0884US11827711B2Antibodies binding to NKG2DHOFFMANN LA ROCHE·Filed 2020·Granted Nov 28, 2023·1 cites·27 claims
- 0983US10730938B2Bispecific antibodies and methods of use in ophthalmologyHOFFMANN LA ROCHE·Filed 2017·Granted Aug 4, 2020·3 cites·13 claims
- 1083US10344085B2Anti-IL-1beta antibodiesHOFFMANN LA ROCHE·Filed 2017·Granted Jul 9, 2019·5 cites·9 claims
- 1183US2024294642A1Anti-pd1 antibodies and methods of useHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 1282US10570188B2Method for producing monomeric and multimeric molecules and uses thereofHOFFMANN LA ROCHE·Filed 2017·Granted Feb 25, 2020·3 cites·3 claims
- 1381US2023183349A1Anti-pd1 antibodies and methods of useHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 1479US2025051456A1Anti-hla-g antibodies and methods of use thereofHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 1579US2024101657A1Antibody that binds to vegf and il-1beta and methods of useHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 1678US10517945B2Covalently linked antigen-antibody conjugatesHOFFMANN LA ROCHE·Filed 2014·Granted Dec 31, 2019·3 cites·16 claims
- 1778US2023143310A1Anti-pd1 antibodies and methods of useHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 1878US2024166771A1Contorsbody - a single chain target binderHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 1978US2025313629A1Anti-lag3 antibodiesHOFFMANN LA ROCHE·Filed 2025·Application pending·0 cites
- 2077US10538585B2Anti-ANG2 antibodies and methods of useHOFFMANN LA ROCHE·Filed 2017·Granted Jan 21, 2020·2 cites·6 claims
- 2177US10519249B2Covalently linked polypeptide toxin-antibody conjugatesHOFFMANN LA ROCHE·Filed 2016·Granted Dec 31, 2019·2 cites·8 claims
- 2277US2024270834A1Novel antibody formatHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 2376US2024002506A1Anti-lag3 antibodiesHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 2475US10407511B2Covalently linked helicar-anti-helicar antibody conjugates and uses thereofHOFFMANN LA ROCHE·Filed 2016·Granted Sep 10, 2019·2 cites·9 claims
- 2575US10087246B2Anti-PDGF-B antibodies and methods of useHOFFMANN LA ROCHE·Filed 2017·Granted Oct 2, 2018·2 cites·14 claims
- 2675US2024067734A1Antibodies binding to NKG2DHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 2773US11866490B2Antibody that binds to VEGF and IL-1beta and methods of useHOFFMANN LA ROCHE·Filed 2021·Granted Jan 9, 2024·0 cites·36 claims
- 2873US2025361326A1Method for generating multispecific antibodies from monospecific antibodiesHOFFMANN LA ROCHE·Filed 2025·Application pending·0 cites
- 2972US11572404B2Humanized anti-Tau(pS422) antibodies and methods of useHOFFMANN LA ROCHE·Filed 2020·Granted Feb 7, 2023·0 cites·6 claims
- 3071US11130804B2Antibody that binds to VEGF and IL-1beta and methods of useHOFFMANN LA ROCHE·Filed 2019·Granted Sep 28, 2021·0 cites·28 claims
- 3171US2023279090A1Non-covalent protein-hyaluronan conjugates for long-acting ocular deliveryGENENTECH INC·Filed 2023·Application pending·0 cites
- 3271US2025051455A1Multispecific antibodies and use thereofHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 3371US2025154249A1Anti-transferrin receptor antibodies with tailored affinityHOFFMANN LA ROCHE·Filed 2025·Application pending·0 cites
- 3471US2023256107A1Hyaluronic acid binding derivatives of versican (vg1) for long acting delivery of therapeuticsGENENTECH INC·Filed 2023·Application pending·0 cites
- 3569US2025361325A1Method for generating multispecific antibodies from monospecific antibodiesHOFFMANN LA ROCHE·Filed 2025·Application pending·0 cites
- 3669US2021347916A1Contorsbody - a single chain target binderHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 3767US11254728B2Method for producing monomeric and multimeric molecules and uses thereofHOFFMANN LA ROCHE·Filed 2020·Granted Feb 22, 2022·0 cites·11 claims
- 3866US12023378B2Covalently linked antigen-antibody conjugatesHOFFMANN LA ROCHE·Filed 2019·Granted Jul 2, 2024·0 cites·21 claims
- 3965US2021171619A1Novel antibody formatHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 4064US12297290B2Method for generating multispecific antibodies from monospecific antibodiesHOFFMANN LA ROCHE·Filed 2020·Granted May 13, 2025·0 cites·15 claims
- 4164US12157770B2Anti-HLA-G antibodies and methods of use thereofHOFFMANN LA ROCHE·Filed 2020·Granted Dec 3, 2024·0 cites·11 claims
- 4264US2025034269A1Agonistic ltbr antibodies and bispecific antibodies comprising themHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 4363US2020277372A1Anti-lag3 antibodiesHOFFMANN LA ROCHE·Filed 2019·Application pending·0 cites
- 4462US2019382489A1Anti-pd1 antibodies and methods of useHOFFMANN LA ROCHE·Filed 2018·Application pending·0 cites
- 4561US12258371B2Stabilized immunoglobulin domainsHOFFMANN LA ROCHE·Filed 2020·Granted Mar 25, 2025·0 cites·10 claims
- 4661US2019218282A1Novel antibody formatHOFFMANN LA ROCHE·Filed 2018·Application pending·0 cites
- 4761US2019389971A1The contorsbody - a single chain target binderHOFFMANN LA ROCHE·Filed 2018·Application pending·0 cites
- 4859US11981737B2Anti-HLA-G antibodies and use thereofHOFFMANN LA ROCHE·Filed 2019·Granted May 14, 2024·0 cites·9 claims
- 4956US2022098305A1Novel icos antibodies and tumor-targeted antigen binding molecules comprising themHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 5056US2017247454A1Anti-pd1 antibodies and methods of useHOFFMANN LA ROCHE·Filed 2016·Application pending·0 cites
Showing the top 50 of 58 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Stefan Dengl files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →